JP2011530540A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011530540A5 JP2011530540A5 JP2011522346A JP2011522346A JP2011530540A5 JP 2011530540 A5 JP2011530540 A5 JP 2011530540A5 JP 2011522346 A JP2011522346 A JP 2011522346A JP 2011522346 A JP2011522346 A JP 2011522346A JP 2011530540 A5 JP2011530540 A5 JP 2011530540A5
- Authority
- JP
- Japan
- Prior art keywords
- dosage form
- pharmaceutical dosage
- tetrahydrobiopterin
- form according
- metabolic precursor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002552 dosage form Substances 0.000 claims 12
- 230000002503 metabolic effect Effects 0.000 claims 9
- 239000002243 precursor Substances 0.000 claims 9
- FNKQXYHWGSIFBK-RPDRRWSUSA-N sapropterin Chemical compound N1=C(N)NC(=O)C2=C1NC[C@H]([C@@H](O)[C@@H](O)C)N2 FNKQXYHWGSIFBK-RPDRRWSUSA-N 0.000 claims 9
- 229960004617 sapropterin Drugs 0.000 claims 9
- 239000007864 aqueous solution Substances 0.000 claims 6
- 239000003963 antioxidant agent Substances 0.000 claims 5
- 230000003078 antioxidant effect Effects 0.000 claims 4
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 3
- 235000018417 cysteine Nutrition 0.000 claims 3
- -1 sulfhydryl compound Chemical class 0.000 claims 3
- 201000011252 Phenylketonuria Diseases 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 2
- REYLLNRLWCBKCM-YFKPBYRVSA-N (2s)-2-acetamido-4-sulfanylbutanoic acid Chemical compound CC(=O)N[C@H](C(O)=O)CCS REYLLNRLWCBKCM-YFKPBYRVSA-N 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 claims 1
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 claims 1
- 206010069116 Tetrahydrobiopterin deficiency Diseases 0.000 claims 1
- 229960004308 acetylcysteine Drugs 0.000 claims 1
- 235000008452 baby food Nutrition 0.000 claims 1
- YVKSGVDJQXLXDV-BYPYZUCNSA-N ethyl (2r)-2-amino-3-sulfanylpropanoate Chemical compound CCOC(=O)[C@@H](N)CS YVKSGVDJQXLXDV-BYPYZUCNSA-N 0.000 claims 1
- FTURCWPZLPUMLY-YFKPBYRVSA-N ethyl (2s)-2-amino-4-sulfanylbutanoate Chemical compound CCOC(=O)[C@@H](N)CCS FTURCWPZLPUMLY-YFKPBYRVSA-N 0.000 claims 1
- 229960001913 mecysteine Drugs 0.000 claims 1
- GPBQMUGQGMBCNZ-BYPYZUCNSA-N methyl (2s)-2-amino-4-sulfanylbutanoate Chemical compound COC(=O)[C@@H](N)CCS GPBQMUGQGMBCNZ-BYPYZUCNSA-N 0.000 claims 1
- MCYHPZGUONZRGO-VKHMYHEASA-N methyl L-cysteinate Chemical compound COC(=O)[C@@H](N)CS MCYHPZGUONZRGO-VKHMYHEASA-N 0.000 claims 1
- 235000013336 milk Nutrition 0.000 claims 1
- 239000008267 milk Substances 0.000 claims 1
- 210000004080 milk Anatomy 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 230000000087 stabilizing effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ATA1254/2008 | 2008-08-12 | ||
| AT12542008 | 2008-08-12 | ||
| PCT/AT2009/000306 WO2010017570A2 (de) | 2008-08-12 | 2009-08-07 | Pharmazeutische darreichungsform enthaltend tetrahydrobiopterin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011530540A JP2011530540A (ja) | 2011-12-22 |
| JP2011530540A5 true JP2011530540A5 (enExample) | 2012-06-07 |
Family
ID=41111155
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011522346A Pending JP2011530540A (ja) | 2008-08-12 | 2009-08-07 | テトラヒドロビオプテリンを含有する医薬剤形 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20110144117A1 (enExample) |
| EP (1) | EP2309983B1 (enExample) |
| JP (1) | JP2011530540A (enExample) |
| ES (1) | ES2736730T3 (enExample) |
| PL (1) | PL2309983T3 (enExample) |
| RU (1) | RU2011109210A (enExample) |
| TR (1) | TR201910287T4 (enExample) |
| WO (1) | WO2010017570A2 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2014202925B2 (en) * | 2013-01-10 | 2015-07-09 | Nutritional Therapeutics, Inc. | Chewable wafers containing lipid supplements for maintaining health and the treatment of acute and chronic disorders |
| EP2926805B1 (en) | 2014-03-31 | 2016-05-18 | Vasopharm GmbH | Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions |
| IL266955B2 (en) | 2016-11-29 | 2023-09-01 | Ptc Therapeutics Mp Inc | Polymorphs of spiafatrin and its salts |
| WO2018102314A1 (en) | 2016-11-29 | 2018-06-07 | Censa Pharmaceuticals Inc. | Polymorphic form of sepiapterin |
| WO2019046849A1 (en) * | 2017-09-01 | 2019-03-07 | Censa Pharmaceuticals Inc. | PHARMACEUTICAL COMPOSITION COMPRISING SEPAPTERINE AND USES THEREOF |
| SMT202400430T1 (it) | 2018-05-30 | 2024-11-15 | Ptc Therapeutics Mp Inc | Somministrazione di sepiapterina, senza alcun alimento, per uso in un metodo per incrementare l’esposizione plasmatica di sepiapterina |
| EP3801534A4 (en) | 2018-05-30 | 2022-03-16 | PTC Therapeutics MP, Inc. | COMPOSITIONS AND METHODS TO INCREASE TETRAHYDROBIOPTERIN PLASMA EXPOSURE |
| JP7553906B2 (ja) * | 2018-11-01 | 2024-09-19 | 宏 一瀬 | Ｓｐｒをコードするポリヌクレオチドを含む組換えベクター、及びそれを含む組成物 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61277618A (ja) * | 1985-06-04 | 1986-12-08 | Suntory Ltd | 自閉症治療剤 |
| JP2588191B2 (ja) * | 1987-04-24 | 1997-03-05 | サントリー株式会社 | 悪性腫瘍および重症ウイルス感染症に伴う神経症状を改善するための治療剤 |
| DE10260263A1 (de) * | 2002-12-20 | 2004-07-15 | Biocrates Life Sciences Gmbh | Verwendung von Tetrahydrobiopterinderivaten zur Behandlung und Ernährung von Patienten mit Aminosäurestoffwechselstörungen |
| WO2005107759A1 (ja) * | 2004-05-11 | 2005-11-17 | Daiichi Asubo Pharma Co., Ltd. | Ｂｈ４反応性高フェニルアラニン血症治療剤 |
| EP2436379A1 (en) * | 2004-11-17 | 2012-04-04 | BioMarin Pharmaceutical Inc. | Stable tablet formulation |
| US20060188492A1 (en) * | 2005-01-13 | 2006-08-24 | Chronorx Llc, An Alaska Limited Liability Company | Topical management of ocular and periocular conditions |
| AU2006245770A1 (en) * | 2005-05-11 | 2006-11-16 | Nycomed Gmbh | Combination of the PDE4 inhibitor roflumilast and a tetrahydrobiopterin derivative |
| DK3461503T3 (da) * | 2007-04-11 | 2022-02-14 | Biomarin Pharm Inc | Fremgangsmåder til indgivelse af tetrahydrobiopterin, associerede sammensætninger og målingsfremgangsmåder |
-
2009
- 2009-08-07 ES ES09775591T patent/ES2736730T3/es active Active
- 2009-08-07 PL PL09775591T patent/PL2309983T3/pl unknown
- 2009-08-07 RU RU2011109210/15A patent/RU2011109210A/ru not_active Application Discontinuation
- 2009-08-07 WO PCT/AT2009/000306 patent/WO2010017570A2/de not_active Ceased
- 2009-08-07 TR TR2019/10287T patent/TR201910287T4/tr unknown
- 2009-08-07 JP JP2011522346A patent/JP2011530540A/ja active Pending
- 2009-08-07 US US13/058,625 patent/US20110144117A1/en not_active Abandoned
- 2009-08-07 EP EP09775591.2A patent/EP2309983B1/de active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011530540A5 (enExample) | ||
| RU2011109210A (ru) | Лекарственная форма, содержащая тетрагидробиоптерин | |
| US11896565B2 (en) | Beta-hydroxybutyrate mixed salt compositions and methods of use | |
| JP2012031131A5 (enExample) | ||
| US20210205241A1 (en) | Beta-hydroxybutyric acid compositionsand methods for oral delivery of ketone bodies | |
| AU2020221031B2 (en) | Beta-hydroxybutyrate mixed salt-acid compositions and methods of use | |
| EP2545939A3 (en) | Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring | |
| JP2013545745A5 (enExample) | ||
| RU2017134002A (ru) | Стабильные композиции тетрагидробиоптерина | |
| HRP20180863T1 (hr) | Aktivatori piruvat kinaze za uporabu u terapiji | |
| JP2020532535A5 (enExample) | ||
| JP2012515184A5 (enExample) | ||
| JP2014530801A5 (enExample) | ||
| JP2017507973A5 (enExample) | ||
| JP2013505233A5 (enExample) | ||
| JP2015505295A5 (enExample) | ||
| JP2011506587A5 (enExample) | ||
| US20250025434A1 (en) | S-beta-hydroxybutyric acid compositions and methods for delivery of ketone bodies | |
| JP2015518038A5 (enExample) | ||
| JP2011068692A5 (enExample) | ||
| WO2004017955A1 (en) | L-arginine containing pharmaceutical composition | |
| RU2014115289A (ru) | Композиция пазопаниба | |
| HRP20200691T1 (hr) | Pedijatrijska formulacija | |
| RU2017145602A (ru) | Жидкие композиции целекоксиба для перорального введения | |
| JP2007055992A5 (enExample) |